These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26647887)

  • 1. [Role of Immunotherapy in Pediatric Oncology].
    Bajčiová V
    Klin Onkol; 2015; 28 Suppl 4():4S38-43. PubMed ID: 26647887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy in pediatric malignancies: current status and future perspectives.
    Capitini CM; Otto M; DeSantes KB; Sondel PM
    Future Oncol; 2014; 10(9):1659-78. PubMed ID: 25145434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunities and challenges in the immunological therapy of pediatric malignancy: a concise snapshot.
    Ceppi F; Beck-Popovic M; Bourquin JP; Renella R
    Eur J Pediatr; 2017 Sep; 176(9):1163-1172. PubMed ID: 28803259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy in Pediatric Oncology: An Overview of Therapy Types and Nursing Implications.
    Warren CB
    Clin J Oncol Nurs; 2018 Dec; 22(6):649-655. PubMed ID: 30452014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Not Available].
    Pasqualini C; Rialland F; Valteau-Couanet D; Michon J; Minard-Colin V
    Bull Cancer; 2018 Dec; 105 Suppl 1():S68-S79. PubMed ID: 30595201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM
    Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From a Patient Advocate's Perspective: Does Cancer Immunotherapy Represent a Paradigm Shift?
    Madden DL
    Curr Oncol Rep; 2018 Feb; 20(1):8. PubMed ID: 29411148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and Antibody Based Approaches for Pediatric Cancer Immunotherapy.
    Huang MA; Krishnadas DK; Lucas KG
    J Immunol Res; 2015; 2015():675269. PubMed ID: 26587548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highlights of the third International Conference on Immunotherapy in Pediatric Oncology.
    Brehm C; Huenecke S; Pfirrmann V; Rossig C; Mackall CL; Bollard CM; Gottschalk S; Schlegel PG; Klingebiel T; Bader P
    Pediatr Hematol Oncol; 2013 Aug; 30(5):349-66. PubMed ID: 23758210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-based therapeutics for pediatric cancer.
    Capitini CM; Mackall CL; Wayne AS
    Expert Opin Biol Ther; 2010 Feb; 10(2):163-78. PubMed ID: 19947897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Immunotherapies for Cancer and Their Potential for Application in Pediatric Oncology.
    Orentas RJ; Mackall CL
    Crit Rev Oncog; 2015; 20(3-4):315-27. PubMed ID: 26349422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature.
    Özdemir BC; Siefker-Radtke AO; Campbell MT; Subudhi SK
    Eur Urol Focus; 2018 Apr; 4(3):442-454. PubMed ID: 29056275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highlights of the second international conference on "Immunotherapy in Pediatric Oncology".
    Capitini CM; Gottschalk S; Brenner M; Cooper LJ; Handgretinger R; Mackall CL
    Pediatr Hematol Oncol; 2011 Sep; 28(6):459-60. PubMed ID: 21854215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining Radiotherapy and Immunotherapy in Lung Cancer: Can We Expect Limitations Due to Altered Normal Tissue Toxicity?
    Wirsdörfer F; de Leve S; Jendrossek V
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing the Immunotherapy Revolution for the Treatment of Childhood Cancers.
    Majzner RG; Heitzeneder S; Mackall CL
    Cancer Cell; 2017 Apr; 31(4):476-485. PubMed ID: 28366678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral and cellular immunotherapy in ALL in children, adolescents, and young adults.
    Hochberg J; El-Mallawany NK; Cairo MS
    Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S6-13. PubMed ID: 25486958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines.
    Lohmueller J; Finn OJ
    Pharmacol Ther; 2017 Oct; 178():31-47. PubMed ID: 28322974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy in Tumors.
    Kobold S; Duewell P; Schnurr M; Subklewe M; Rothenfusser S; Endres S
    Dtsch Arztebl Int; 2015 Nov; 112(48):809-15. PubMed ID: 26667979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic Modulation of Human Immunity in the Era of Immuno-oncology: Something Old, Something New.
    Bangalore Kumar A; Maus R; Markovic SN
    Mayo Clin Proc; 2018 Jul; 93(7):917-936. PubMed ID: 29887221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
    Chung C
    Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.